| 1 |
34167436 | miR-4486 enhances cisplatin sensitivity of gastric cancer cells by restraining the JAK3/STAT3 signalling pathway. | 2022 Feb |
2 |
| 2 |
34656559 | Cisplatin resistance of NSCLC cells involves upregulation of visfatin through activation of its transcription and stabilization of mRNA. | 2022 Jan 5 |
2 |
| 3 |
35139763 | Cancer-associated fibroblast exosomes promote chemoresistance to cisplatin in hepatocellular carcinoma through circZFR targeting signal transducers and activators of transcription (STAT3)/ nuclear factor -kappa B (NF-κB) pathway. | 2022 Mar |
1 |
| 4 |
35472743 | Thalidomide-based Pt(IV) prodrugs designed to exert synergistic effect of immunomodulation and chemotherapy. | 2022 Jul |
1 |
| 5 |
35599281 | Synergistic antitumor effect of Andrographolide and cisplatin through ROS-mediated ER stress and STAT3 inhibition in colon cancer. | 2022 May 23 |
3 |
| 6 |
35628594 | Nimodipine Treatment Protects Auditory Hair Cells from Cisplatin-Induced Cell Death Accompanied by Upregulation of LMO4. | 2022 May 21 |
2 |
| 7 |
32526010 | IL-23R in laryngeal cancer: a cancer immunoediting process that facilitates tumor cell proliferation and results in cisplatin resistance. | 2021 Feb 11 |
1 |
| 8 |
33345849 | IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells. | 2021 Mar 5 |
1 |
| 9 |
33536189 | Lipidome-based Targeting of STAT3-driven Breast Cancer Cells Using Poly-l-glutamic Acid-coated Layer-by-Layer Nanoparticles. | 2021 Apr |
1 |
| 10 |
33634982 | Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF-kB signaling pathways synergistically. | 2021 Feb |
2 |
| 11 |
33878452 | Atezolizumab and blockade of LncRNA PVT1 attenuate cisplatin resistant ovarian cancer cells progression synergistically via JAK2/STAT3/PD-L1 pathway. | 2021 Jun |
1 |
| 12 |
33982773 | PHF20 inhibition promotes apoptosis and cisplatin chemosensitivity via the OCT4‑p‑STAT3‑MCL1 signaling pathway in hypopharyngeal squamous cell carcinoma. | 2021 Jul |
2 |
| 13 |
34094941 | lncRNA MIAT/HMGB1 Axis Is Involved in Cisplatin Resistance via Regulating IL6-Mediated Activation of the JAK2/STAT3 Pathway in Nasopharyngeal Carcinoma. | 2021 |
2 |
| 14 |
34139285 | Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma. | 2021 Oct 10 |
1 |
| 15 |
34216662 | A novel platform for drug testing: Biomimetic three-dimensional hyaluronic acid-based scaffold seeded with human hepatocarcinoma cells. | 2021 Aug 31 |
1 |
| 16 |
34239773 | Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients. | 2021 |
1 |
| 17 |
34321456 | miR-526b-3p inhibits lung cancer cisplatin-resistance and metastasis by inhibiting STAT3-promoted PD-L1. | 2021 Jul 28 |
1 |
| 18 |
34329824 | Improved tumor-suppressive effect of OZ-001 combined with cisplatin mediated by mTOR/p70S6K and STAT3 inactivation in A549 human lung cancer cells. | 2021 Oct |
3 |
| 19 |
34375503 | ZIPK activates the IL-6/STAT3 signaling pathway and promotes cisplatin resistance in gastric cancer cells. | 2021 Sep |
4 |
| 20 |
34496932 | ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer. | 2021 Sep 8 |
2 |
| 21 |
34543857 | STAT3 contributes to cisplatin resistance, modulating EMT markers, and the mTOR signaling in lung adenocarcinoma. | 2021 Sep 17 |
5 |
| 22 |
34549307 | SPHK1 contributes to cisplatin resistance in bladder cancer cells via the NONO/STAT3 axis. | 2021 Nov |
1 |
| 23 |
34612768 | Chaperonin containing TCP1 subunit 3 (CCT3) promotes cisplatin resistance of lung adenocarcinoma cells through targeting the Janus kinase 2/signal transducers and activators of transcription 3 (JAK2/STAT3) pathway. | 2021 Dec |
1 |
| 24 |
31790894 | Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3. | 2020 Jan |
1 |
| 25 |
31936675 | Curcumin-Mediated Apoptotic Cell Death in Papillary Thyroid Cancer and Cancer Stem-Like Cells through Targeting of the JAK/STAT3 Signaling Pathway. | 2020 Jan 9 |
3 |
| 26 |
31974389 | The dual role of curcumin and ferulic acid in counteracting chemoresistance and cisplatin-induced ototoxicity. | 2020 Jan 23 |
1 |
| 27 |
32010312 | Interleukin-22 modulates cisplatin sensitivity of osteosarcoma cells by regulating the STAT3 signaling pathway. | 2020 Feb |
1 |
| 28 |
32080166 | ID1 confers cancer cell chemoresistance through STAT3/ATF6-mediated induction of autophagy. | 2020 Feb 20 |
1 |
| 29 |
32170433 | CircAKT3 inhibits glycolysis balance in lung cancer cells by regulating miR-516b-5p/STAT3 to inhibit cisplatin sensitivity. | 2020 Jul |
1 |
| 30 |
32252293 | Expression of CD44v6-Containing Isoforms Influences Cisplatin Response in Gastric Cancer Cells. | 2020 Apr 2 |
1 |
| 31 |
32351887 | Combinatorial Low Dose Arsenic Trioxide and Cisplatin Exacerbates Autophagy via AMPK/STAT3 Signaling on Targeting Head and Neck Cancer Initiating Cells. | 2020 |
2 |
| 32 |
32661236 | Low GAS5 expression may predict poor survival and cisplatin resistance in cervical cancer. | 2020 Jul 13 |
1 |
| 33 |
32705214 | A small molecule STAT3 inhibitor, LLL12, enhances cisplatin‑ and paclitaxel‑mediated inhibition of cell growth and migration in human ovarian cancer cells. | 2020 Sep |
3 |
| 34 |
32757663 | HOTAIR Promotes Cisplatin Resistance of Osteosarcoma Cells by Regulating Cell Proliferation, Invasion, and Apoptosis via miR-106a-5p/STAT3 Axis. | 2020 Jan-Dec |
1 |
| 35 |
32767949 | A Ferrocene Derivative Reduces Cisplatin Resistance in Breast Cancer Cells through Suppression of MDR-1 Expression and Modulation of JAK2/STAT3 Signaling Pathway. | 2020 |
3 |
| 36 |
32828740 | Central nervous system (CNS) tumor cell heterogeneity contributes to differential platinum-based response in an in vitro 2D and 3D cell culture approach. | 2020 Oct |
1 |
| 37 |
32901049 | Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling. | 2020 Sep 8 |
2 |
| 38 |
33023532 | TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells. | 2020 Oct 6 |
1 |
| 39 |
33044324 | Long noncoding RNA nuclear-enriched abundant transcript 1 regulates proliferation and apoptosis of neuroblastoma cells treated by cisplatin by targeting miR-326 through Janus kinase/signal transducer and activator of transcription 3 pathway. | 2020 Dec 9 |
2 |
| 40 |
33116826 | ARHGAP6 Promotes Apoptosis and Inhibits Glycolysis in Lung Adenocarcinoma Through STAT3 Signaling Pathway. | 2020 |
6 |
| 41 |
30332965 | Targeting Upstream Kinases of STAT3 in Human Medulloblastoma Cells. | 2019 |
1 |
| 42 |
30352127 | Growth arrest-specific 5 attenuates cisplatin-induced apoptosis in cervical cancer by regulating STAT3 signaling via miR-21. | 2019 Jun |
1 |
| 43 |
30483799 | Erythropoietin promotes expression of survivin via STAT3 activation and reduces sensitivity to cisplatin in cervical cancer cells. | 2019 Feb |
1 |
| 44 |
30747218 | Gallic acid has anticancer activity and enhances the anticancer effects of cisplatin in non‑small cell lung cancer A549 cells via the JAK/STAT3 signaling pathway. | 2019 Mar |
2 |
| 45 |
30777616 | Effect of lncRNA ANRIL knockdown on proliferation and cisplatin chemoresistance of osteosarcoma cells in vitro. | 2019 May |
1 |
| 46 |
30808674 | Retinoic Acid-Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer. | 2019 May 15 |
1 |
| 47 |
30811078 | The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin. | 2019 Nov |
4 |
| 48 |
30961670 | Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway. | 2019 Apr 8 |
3 |
| 49 |
31037726 | Modulation of Myb-induced NF-kB -STAT3 signaling and resulting cisplatin resistance in ovarian cancer by dietary factors. | 2019 Nov |
1 |
| 50 |
31105696 | Atezolizumab and Bevacizumab Attenuate Cisplatin Resistant Ovarian Cancer Cells Progression Synergistically via Suppressing Epithelial-Mesenchymal Transition. | 2019 |
1 |